Medication Fact Sheets
|
December 10, 2024

Cyclobenzaprine: Benefits, Dosage Options, and Warnings

Medically Reviewed by
Updated On
December 18, 2024

Cyclobenzaprine is one of the most frequently prescribed muscle relaxants to treat muscle spasms, often accompanying acute musculoskeletal conditions such as strains or injuries.Β 

Muscle spasms can be painful and disruptive, and cyclobenzaprine works by calming the overactive muscles, helping patients regain mobility and comfort.

This article is written for healthcare professionals who wish to educate their patients and individuals seeking an in-depth yet easy-to-understand guide on cyclobenzaprine. Whether you're a provider discussing options with a patient or someone dealing with muscle pain, this guide aims to clarify key aspects of cyclobenzaprine's usage.

Our goal is to cover the benefits, dosage options, side effects, and warnings associated with cyclobenzaprine to ensure safe and effective use, minimize risks, and make informed decisions.

[signup]

What is Cyclobenzaprine?

Cyclobenzaprine is a muscle relaxant frequently prescribed to relieve acute muscle spasms and discomfort, providing short-term support as part of a broader treatment plan. But how does it work?

Mechanism of Action

Cyclobenzaprine works by blocking nerve impulsesβ€”or pain sensationsβ€”that are sent to the brain.Β 

Think of muscle spasms as an electrical storm in the body, where muscles receive repeated, unnecessary signals to contract. Cyclobenzaprine acts like a protective switch, calming this hyperactivity in the central nervous system and relaxing the muscles.

Indications for Use

Cyclobenzaprine is primarily used to relieve muscle spasms related to acute musculoskeletal conditions such as muscle strains or sprains. It is not suitable for treating muscle spasms caused by chronic conditions, such as cerebral palsy or multiple sclerosis.Β 

Instead, it is best reserved for short-term use, typically as part of a comprehensive treatment plan that includes rest and physical therapy.

Cyclobenzaprine 5 mg vs. 10 mg

Cyclobenzaprine is available in two primary strengths: 5 mg and 10 mg tablets. When choosing between dosages, several factors must be considered, including severity of symptoms, patient age, and tolerance to potential side effects.

Dosage Differences and How to Take

The 5 mg dose may be prescribed for mild cases or when lower doses are preferable due to potential side effects. The 10 mg option is more commonly prescribed for moderate to severe muscle spasms.Β 

Cyclobenzaprine is typically taken two to three times daily, depending on the strength and severity of symptoms.Β 

It is essential for patients to adhere to their doctor's prescription and avoid exceeding the recommended duration of use - typically no more than 2-3 weeks, and long-term use can increase the risk of side effects and dependency.

Considerations for Different Patient PopulationsΒ 

Factors like a patient's age, weight, and the severity of the condition determine the appropriate dosage. For example, older and younger patients or those with liver impairments may require lower doses.

  • Elderly Patients: Lower doses are generally recommended due to increased sensitivity to the drug and a higher risk of side effects like confusion or dizziness.
  • Patients with Liver Impairment: Those with liver conditions may require a reduced dose or careful monitoring as the liver processes the medication.
  • Pediatric Usage: Cyclobenzaprine is generally not recommended for children under 15 years old due to a lack of safety and efficacy data.

Effectiveness of Cyclobenzaprine

Cyclobenzaprine is widely recognized for its ability to provide rapid relief from muscle spasms, making it a key component of short-term treatment plans for acute musculoskeletal conditions.

How Quickly Does Cyclobenzaprine Work?

Cyclobenzaprine generally begins to work within 20 to 30 minutes of oral administration, with its peak effects typically occurring within 1 to 4 hours.Β 

Muscle relaxation can last anywhere from 12 to 24 hours, depending on the dosage and the individual's metabolism. Full therapeutic effects often develop after several doses, with notable improvements reported by day 3-4 of consistent use.Β 

This rapid onset relieves painful muscle spasms, making it a popular choice for short-term management.

To achieve recovery from muscle injuries, cyclobenzaprine works well when paired with physical therapy and adequate rest. Muscle spasms and cramps often result from trauma or strain, and while cyclobenzaprine helps by relaxing the muscles, physical therapy plays a vital role in rebuilding strength and improving function.Β 

Cyclobenzaprine can be thought of as a supportive toolβ€”like a brace for a sprained ankleβ€”that provides short-term relief while you focus on healing and regaining mobility through targeted exercises.

Cyclobenzaprine Side Effects

Understanding the potential side effects of cyclobenzaprine is essential for safe use, as these can range from common, mild temporary discomforts to more serious and rare complications.

Common Side Effects

While cyclobenzaprine is effective at relieving muscle spasms, it comes with potential side effects, many of which are mild and temporary. Common side effects include:

  • Drowsiness: About 30% of patients report a feeling of sedation or fatigue caused by its histamine H1 antagonism, which can impair activities like driving.
  • Dry Mouth: Anticholinergic effects cause a lack of saliva production and dry mouth. Drinking water or chewing sugar-free gum can alleviate this.
  • Dizziness: This can be caused by central nervous system effects, particularly when standing up quickly.
  • Constipation: Similarly to dry mouth, difficulty with bowel movements can occur due to the anticholinergic effects. This can be managed with dietary adjustments.

Severe and Notable Side Effects/Risks

Although rare, serious side effects can occur. These include:

  • Serotonin Syndrome: A potentially life-threatening condition that can arise when cyclobenzaprine is taken with other serotonergic drugs. Symptoms include agitation, hallucinations, rapid heart rate, and fever.
  • Heart Arrhythmias: Abnormal heart rhythms have been observed, which can be dangerous for those with preexisting heart conditions.
  • Extrapyramidal Symptoms: Rare occurrences of motor effects like torticollis have been reported, especially in cases of liver impairment.Β 

Contraindications

Cyclobenzaprine should not be used in certain situations, such as:

  • Recent Heart Attack: Due to its similarity to tricyclic antidepressants, patients who have had a heart attack should avoid using cyclobenzaprine because of its potential to worsen arrhythmias.
  • Certain Heart Conditions: Similarly, those with arrhythmias or heart block should consult their physician, as cyclobenzaprine can exacerbate these conditions.
  • Hyperthyroidism: Patients with an overactive thyroid should be cautious, as the drug may increase the risk of complications due to its cardiovascular effects.

Safety Considerations

When using cyclobenzaprine, it is essential to understand potential safety concerns, including how it interacts with other medications, to minimize risks and ensure effective treatment.

Interactions

Cyclobenzaprine can interact with various medications, amplifying risks or diminishing effectiveness. Key interactions include:

  • MAO Inhibitors: Taking cyclobenzaprine with MAO inhibitors (such as phenelzine, selegiline, tranylcypromine, and isocarboxazid) can lead to dangerous interactions, such as serotonin syndrome. Cyclobenzaprine use should be avoided within 14 days of MAOI therapy.
  • CNS Depressants: Combining with drugs like benzodiazepines or opioids can increase the likelihood of severe drowsiness and respiratory depression. Similarly, medications like antihistamines or gabapentinoids can interact in this way as well.
  • Alcohol: Due to enhancing the sedative effects of cyclobenzaprine, alcohol should be avoided.

Other Considerations

  • Cyclobenzaprine is designed for short-term use and is not typically recommended for extended periods.Β 
  • Using the medication for too long may increase the risk of dependency or withdrawal symptoms.Β 
  • When stopping cyclobenzaprine, it's important not to discontinue it suddenly. Instead, patients should work with their doctor to gradually taper the dose if needed.

The safety of cyclobenzaprine during pregnancy has not been fully established. Its use should be considered only if the potential benefits outweigh the associated risks to the developing baby.

Breastfeeding mothers should use caution, as it is unclear whether the drug passes into the breast milk or how it may affect the infant. Be sure to consult a healthcare provider before use.

Patient Education and Best Practices

Understanding how to use cyclobenzaprine safely and effectively is essential for minimizing side effects and achieving the best outcomes during treatment.

Tips for Safe Use of Cyclobenzaprine

  • Follow Prescriptions Strictly: Always adhere to the prescribed dose and duration. Cyclobenzaprine's effects are dose-dependent, and following your prescriber's directions is important to avoid unwanted side effects.
  • Avoid Driving: Since cyclobenzaprine can cause drowsiness and decreased motor coordination, avoid operating heavy machinery or driving.
  • Limit Alcohol Consumption: Alcohol can increase sedative effects such as sedation and respiratory depression and should be avoided.

Managing Side Effects

If side effects become severe or persistent, seek medical advice.

When to Contact a Healthcare Provider

Seek immediate medical attention if you experience any of the following symptoms:

  • Irregular Heartbeat: A racing or pounding heart could indicate arrhythmia.
  • Severe Allergic Reaction: Although rare, any swelling, difficulty breathing, or rash could indicate a hypersensitivity or allergic reaction.
  • Symptoms of Serotonin Syndrome: Another rare but serious side effect. Symptoms to be aware of include confusion, fever, or severe agitation.

Alternative Treatments for Muscle Spasms

When considering alternatives to cyclobenzaprine, non-pharmacological approaches can provide effective relief for muscle spasms while minimizing the risks associated with medication use.

Non-Pharmacological Approaches

Some patients may benefit from non-drug approaches, including:

  • Physical Therapy: Early intervention with physical therapy can prevent chronic pain and promote recovery from acute injuries.Β 
  • Massage Therapy: Evidence shows that massage therapy effectively relieves muscle tension and promotes blood flow, which can improve both pain and functional outcomes.
  • Heat and Cold Therapy: Using hot packs helps to improve blood flow and relax muscles, and ice helps to reduce pain and inflammation.

Other Medications

Other muscle relaxants are available, such as:

  • Methocarbamol: Known for causing less drowsiness than cyclobenzaprine.
  • Tizanidine: Often used for spasticity and may be preferred for patients with neurological conditions, such as multiple sclerosis.
  • Baclofen: Another option that works differently but can be useful for chronic muscle spasms. Baclofen works by inhibiting spinal reflexes, though it may cause more muscle weakness when compared to other agents.

[signup]

Key Takeaways

  • Overview and Use: Cyclobenzaprine is a commonly prescribed muscle relaxant for acute musculoskeletal conditions like strains or injuries. It helps reduce painful muscle spasms by calming hyperactive nerves in the central nervous system, making it most effective when combined with rest and physical therapy.
  • Dosage and Special Populations: Available in 5 mg and 10 mg tablets, it is typically taken 2-3 times daily for up to 2-3 weeks. Lower doses are advised for elderly patients and those with liver impairments, while it is generally not advised for children under 15 years of age.
  • Effectiveness and Onset: Cyclobenzaprine begins working within 20-30 minutes and peaks within 1-4 hours, providing relief for up to 24 hours. It is a short-term tool that helps patients recover, while physical therapy addresses long-term muscle function.
  • Side Effects and Risks: Common side effects include drowsiness, dry mouth, dizziness, and constipation. Severe risks, such as serotonin syndrome, heart arrhythmias, and allergic reactions, are rare but require immediate medical attention. It is contraindicated in patients with recent heart attacks, certain heart conditions, or hyperthyroidism.
  • Safety Considerations: Cyclobenzaprine interacts with MAO inhibitors, CNS depressants, and alcohol, increasing risks of sedation or respiratory depression. It should not be used long-term due to dependency risks, and its safety during pregnancy or breastfeeding is unclear, requiring consultation with a healthcare provider.
  • Alternative Treatments: Non-drug approaches like physical therapy, massage, and heat/cold therapy can be effective. Other muscle relaxants, such as methocarbamol, tizanidine, and baclofen, may offer alternative options depending on the patient's condition and needs.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Ashby, P., Burke, D., Rao, S., & Jones, R. F. (1972). Assessment of cyclobenzaprine in the treatment of spasticity. Journal of Neurology, Neurosurgery & Psychiatry, 35(5), 599–605. https://doi.org/10.1136/jnnp.35.5.599

Bebarta, V. S., Maddry, J., Borys, D. J., & Morgan, D. L. (2010). Incidence of tricyclic antidepressant-like complications after cyclobenzaprine overdose. The American Journal of Emergency Medicine, 29(6), 645–649. https://doi.org/10.1016/j.ajem.2010.01.014

Borenstein, D. G., & Korn, S. (2003). Efficacy of a low-dose regimen of cyclobenzaprine hydrochloride in acute skeletal muscle spasm: Results of two placebo-controlled trials. Clinical Therapeutics, 25(4), 1056–1073. https://doi.org/10.1016/s0149-2918(03)80067-x

Borenstein, D. G., Lacks, S., & Wiesel, S. W. (1990). Cyclobenzaprine and naproxen versus naproxen alone in the treatment of acute low back pain and muscle spasm. Clinical Therapeutics, 12(2), 125–131. https://pubmed.ncbi.nlm.nih.gov/2141299/

Brioschi, T. M. de L. S., Schramm, S. G., Kano, E. K., Koono, E. E. M., Ching, T. H., Serra, C. H. dos R., & Porta, V. (2013). Pharmacokinetics and Bioequivalence Evaluation of Cyclobenzaprine Tablets. BioMed Research International, 2013, 1–6. https://doi.org/10.1155/2013/281392

Bryant, A. (2024, August 2). Understanding Arrhythmias: Types, Symptoms, Diagnosis, and Treatment. Rupa Health. https://www.rupahealth.com/post/arrhythmias-basics-types-symptoms-diagnosis-treatment

Chou, R., Peterson, K., & Helfand, M. (2004). Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. Journal of Pain and Symptom Management, 28(2), 140–175. https://doi.org/10.1016/j.jpainsymman.2004.05.002

Cimolai, N. (2009). Cyclobenzaprine: a new look at an old pharmacological agent. Expert Review of Clinical Pharmacology, 2(3), 255–263. https://doi.org/10.1586/ecp.09.5

Clijsen, R., Stoop, R., Hohenauer, E., Aerenhouts, D., Clarys, P., Deflorin, C., & Taeymans, J. (2022). Local Heat Applications as a Treatment of Physical and Functional Parameters in Acute and Chronic Musculoskeletal Disorders or Pain. Archives of Physical Medicine and Rehabilitation, 103(3), 505–522. https://doi.org/10.1016/j.apmr.2021.06.015

Cloyd, J. (2023a, June 28). Complementary and Integrative Medicine Options for Patients With Liver Disease: Comprehensive Lab Testing, Nutrition, and Supplement Suggestions. Rupa Health. https://www.rupahealth.com/post/a-functional-and-integrative-medicine-approach-to-treating-liver-disease-comprehensive-testing-nutrition-and-treatment-options

Cloyd, J. (2023b, September 28). A Holistic Functional Medicine Protocol For Multiple Sclerosis. Rupa Health. https://www.rupahealth.com/post/a-holistic-functional-medicine-protocol-for-multiple-sclerosis

Darwish, M., Hellriegel, E. T., & Xie, F. (2008). Single-Dose Pharmacokinetics of Once-Daily Cyclobenzaprine Extended Release 30 mg versus Cyclobenzaprine Immediate Release 10 mg Three Times Daily in Healthy Young Adults. Clinical Drug Investigation, 28(12), 793–801. https://doi.org/10.2165/0044011-200828120-00007

DePorto, T. (2022, December 9). Functional Medicine Lab Tests for Heart Disease. Rupa Health. https://www.rupahealth.com/post/worried-about-heart-disease-ask-your-provider-for-these-6-specialty-labs-at-your-next-appointment

Diorio, B. (2022, November 3). Brain Fog, Muscles Weakness, and Constipation are Symptoms That This Neurotransmitter Could Be Low. Rupa Health. https://www.rupahealth.com/post/poor-short-term-memory-muscles-weakness-and-constipation-are-symptoms-of-low-levels-of-this-neurotransmitter

Eubanks, J. E., Chang Chien, G. C., & Atchison, J. W. (2019). Manipulation, Mobilization, Massage and Traction in Pain Management. Pain, 1047–1049. https://doi.org/10.1007/978-3-319-99124-5_223

Groves, L., Shellenberger, M. K., & Davis, C. S. (1998). Tizanidine treatment of spasticity: a meta-analysis of controlled, double-masked, comparative studies with baclofen and diazepam. Advances in Therapy, 15(4), 241–251. https://pubmed.ncbi.nlm.nih.gov/10186943/

Keegan, M. T., Brown, D. R., & Rabinstein, A. A. (2006). Serotonin syndrome from the interaction of cyclobenzaprine with other serotoninergic drugs. Anesthesia and Analgesia, 103(6), 1466–1468. https://doi.org/10.1213/01.ane.0000247699.81580.eb

Khakham, C. (2023, October 3). The Future of Physical Therapy: How AI is Transforming Rehabilitation and Injury Prevention. Rupa Health. https://www.rupahealth.com/post/the-future-of-physical-therapy-how-ai-is-transforming-rehabilitation-and-injury-prevention

Khan, I., & Kahwaji, C. I. (2020). Cyclobenzaprine. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK513362/

Lee, C., Wanson, A., Frangou, S., Chong, D., & Halpape, K. (2021). Opioid toxicity due to CNS depressant polypharmacy: A case report. The Mental Health Clinician, 11(2), 70–74. https://doi.org/10.9740/mhc.2021.03.070

Long-term Use of Cyclobenzaprine for Pain: A Review of the Clinical Effectiveness. (2015). In PubMed. Canadian Agency for Drugs and Technologies in Health. https://pubmed.ncbi.nlm.nih.gov/25763449/

Malanga, G. A., Yan, N., & Stark, J. (2014). Mechanisms and efficacy of heat and cold therapies for musculoskeletal injury. Postgraduate Medicine, 127(1), 57–65. https://doi.org/10.1080/00325481.2015.992719

Mayo Clinic. (n.d.). Cyclobenzaprine (Oral Route) Description and Brand Names - Mayo Clinic. Www.mayoclinic.org. https://www.mayoclinic.org/drugs-supplements/cyclobenzaprine-oral-route/description/drg-20063236

Medscape. (2010). Flexeril, Amrix (cyclobenzaprine) dosing, indications, interactions, adverse effects, and more. Reference.medscape.com. https://reference.medscape.com/drug/flexeril-amrix-Flexmid-cyclobenzaprine-343338

Moniri, N., Senatorov, I., Cheshmehkani, A., Karmokar, P., & Singh, K. (2021). The skeletal muscle relaxer cyclobenzaprine is a potent non‐competitive histamine H1 receptor antagonist. The FASEB Journal, 35(S1). https://doi.org/10.1096/fasebj.2021.35.s1.02020

Reuss, R., Reuter, I., Jauss, M., Fischer, F., MΓΌller, S. C., & Stolz, E. (2009). Torticollis under Cyclobenzaprine. Pharmacology, 84(2), 91–92. https://doi.org/10.1159/000227773

Robinson, K. (2024, September 11). Muscle Cramps in Hands: Diagnosis, Treatment, and Prevention. Rupa Health. https://www.rupahealth.com/post/muscle-cramps-in-hands-diagnosis-treatment-and-prevention

Shprecher, D., Sloan, C. T., & Sederholm, B. (2013). Neuropsychiatric side effects of cyclobenzaprine. Case Reports, 2013(may02 1), bcr2013008997–bcr2013008997. https://doi.org/10.1136/bcr-2013-008997

Spiller, H. A., Winter, M. L., Mann, K. V., Borys, D. J., Muir, S., & Krenzelok, E. P. (1995). Five-year multicenter retrospective review of cyclobenzaprine toxicity. ˜The œJournal of Emergency Medicine/˜the œJournal of Emergency Medicine (S.l. Online), 13(6), 781–785. https://doi.org/10.1016/0736-4679(95)02019-5

Sweetnich, J. (2023, June 15). Top Specialty Lab Tests for Breast Feeding Moms and Their Babies. Rupa Health. https://www.rupahealth.com/post/top-specialty-lab-test-for-breast-feeding-moms-and-their-babies

TOTH, P., & URTIS, J. (2004). Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone. Clinical Therapeutics, 26(9), 1355–1367. https://doi.org/10.1016/j.clinthera.2004.09.008

Turturro, M. A., Frater, C. R., & D’Amico, F. J. (2003). Cyclobenzaprine with ibuprofen versus ibuprofen alone in acute myofascial strain: A randomized, double-blind clinical trial. Annals of Emergency Medicine, 41(6), 818–826. https://doi.org/10.1067/mem.2003.188

Voshaar, R. C. O., Gorgels, W. J. M. J., Mol, A. J. J., Van Balkom, A. J. L. M., Van De Lisdonk, E. H., Breteler, M. H. M., Van Den Hoogen, J. M., & Zitman, F. G. (2003). Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial. British Journal of Psychiatry, 182(6), 498–504. https://doi.org/10.1192/bjp.182.6.498

Wagstaff, A. J., & Bryson, H. M. (1997). Tizanidine. Drugs, 53(3), 435–452. https://doi.org/10.2165/00003495-199753030-00007

Weathermon, R., & Crabb, D. W. (2024). Alcohol and Medication Interactions. Alcohol Research & Health, 23(1), 40. https://pmc.ncbi.nlm.nih.gov/articles/PMC6761694/

Weil, A. J., Ruoff, G. E., Nalamachu, S., Altman, C. A., Xie, F., & Taylor, D. R. (2010). Efficacy and Tolerability of Cyclobenzaprine Extended Release for Acute Muscle Spasm: A Pooled Analysis. Postgraduate Medicine, 122(4), 158–169. https://doi.org/10.3810/pgm.2010.07.2182

Weinberg, J. (2023, February 7). A Functional Medicine Protocol for Hyperthyroidism. Rupa Health. https://www.rupahealth.com/post/5-functional-medicine-labs-that-can-assist-a-root-cause-treatment-for-hyperthyroidism

Wessel, T., Caron, J., & Kay, G. (2018). 276 No Evidence of Sedation of Tolperisone Compared to Cyclobenzaprine in a Crossover Driving Simulation Study. Annals of Emergency Medicine, 72(4), S109. https://doi.org/10.1016/j.annemergmed.2018.08.281

Winchell, G. A., King, J. D., Chavez-Eng, C. M., Constanzer, M. L., & Korn, S. H. (2002). Cyclobenzaprine Pharmacokinetics, Including the Effects of Age, Gender, and Hepatic Insufficiency. The Journal of Clinical Pharmacology, 42(1), 61–69. https://doi.org/10.1177/0091270002042001007

Wright, A., & Sluka, K. A. (2001). Nonpharmacological Treatments for Musculoskeletal Pain. The Clinical Journal of Pain, 17(1), 33. https://journals.lww.com/clinicalpain/fulltext/2001/03000/nonpharmacological_treatments_for_musculoskeletal.6.aspx

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless β€” and best of all, it's free for practitioners.

Latest Articles

View more on Medication Fact Sheets
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey practitioners! πŸ‘‹ Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.

Hey practitioners! πŸ‘‹ Join Dr. Terry Wahls for a 3-week bootcamp on integrating functional medicine into conventional practice, focusing on complex cases like Multiple Sclerosis. Learn to analyze labs through a functional lens, perform nutrition-focused physical exams, and develop personalized care strategies. Register Here.